Navigation Links
BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences
Date:2/27/2013

LYNBROOK, N.Y., Feb. 27, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S., announced today that BioSpecifics' President, Tom Wegman , will present at the following upcoming investor conferences.

  • Cowen and Company 33rd Annual Health Care Conference (Boston, MA)
    Wednesday, March 6, 2013 at 8:40 a.m. EST

  • ROTH Capital Partners 25th Annual Conference (Laguna Niguel, CA)
    Monday, March 18, 2013 at 5:00 p.m. PDT (8:00 p.m. EDT)

The live webcasts of these presentations can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications. Injectable collagenase is currently marketed as XIAFLEX® in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord by Auxilium Pharmaceuticals, Inc. (Auxilium) and is approved for Dupuytren's contracture in the European Union, Switzerland and Canada. XIAFLEX is also in clinical development for the treatment of several additional promising indications. A supplemental Biologics License Application is currently under standard review at the U.S. Food and Drug Administration for XIAFLEX for the potential treatment of Peyronie's disease. Auxilium is also testing XIAFLEX for frozen shoulder syndrome (adhesive capsulitis) and cellulite in Phase IIa and Phase Ib clinical trials, respectively. BioSpecifics is currently managing the clinical development of XIAFLEX for the treatment of human lipoma and canine lipoma, which are both in Phase II clinical trials. Auxilium is currently partnered with Asahi Kasei Pharma Corporation for the development and commercialization of injectable collagenase for Dupuytren's contracture and Peyronie's disease in Japan and with Actelion Pharmaceuticals Ltd. for these same indications in Canada, Australia, Brazil and Mexico. Pfizer Inc. has marketing rights to XIAPEX® (the EU trade name for XIAFLEX) for Dupuytren's contracture in 46 countries in Eurasia through April 24, 2013.  For more information, please visit www.biospecifics.com.


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
2. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
3. BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September
4. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
6. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
7. Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.
8. Medisafe 1 Technologies One-Time Special Dividend Announced
9. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
10. Leading Breast Surgeons Highlight Techniques and Visualization Technologies for Improved Clinical and Aesthetic Outcomes at Invuitys Surgeon Educational Symposium
11. TOA Technologies mobile healthcare service solutions unite personalized service and efficiency to deliver an enhanced patient experience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2019)... ... 2019 , ... “Comprehensive Vital Organ Biomarkers Analysis of the Consciousness Energy Healing ... No. 1 International Best Seller on Amazon in many categories including Cell Biology, Biology, ... Nosology, and Reference. , The aim of Balmer’s work was to study the ...
(Date:11/16/2019)... ... November 16, 2019 , ... International Splash Awards 2019 winners were announced and ... , Srijan got nominated for its efforts at the world-class competition acknowledging the best ... under tools and apps category. The event was organized in conjunction with DrupalCon Amsterdam ...
(Date:11/15/2019)... ... November 15, 2019 , ... Unlike fine wine, shoulder joints ... shoulder impingement syndrome and rotator cuff disease – rise after age 50, says orthopedic ... limbs. , Impingement syndrome occurs when the uppermost tendon of the rotator cuff – ...
Breaking Medicine Technology:
(Date:11/16/2019)... ... 2019 , ... MemoryCare.com , a comprehensive resource for ... Care Facilities in Amarillo, Texas. The guide identifies 5 memory care communities based ... the Alzheimer’s Association , 5.6 million people age 65 and older are ...
(Date:11/16/2019)... , ... November 16, 2019 , ... ... support AdventHealth, one of the nation’s largest faith-based health systems, as it underwent ... massive program implementation process – from product selection to fitting events to uniform ...
(Date:11/15/2019)... ... 15, 2019 , ... DataTribe , a global cyber ... nation-state experienced technical teams from the intelligence community, research labs, and industry-leading experts, ... Inc ., based in Northport, New York. , The DataTribe Challenge ...
(Date:11/14/2019)... ... November 14, 2019 , ... ... Care System reminds community members, businesses and organizations about the benefits of supporting ... movement that inspires hundreds of millions of people to give, collaborate and celebrate ...
(Date:11/14/2019)... ... 14, 2019 , ... EMulate Therapeutics, Inc., a clinical-stage therapeutic ... will have 5 poster presentations related to its medical devices for treating adult ... Meeting in Phoenix, beginning on November 20 . , Two posters ...
Breaking Medicine News(10 mins):